Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.

Ayinalem Alemu,Zebenay Workneh Bitew,Getu Diriba,Getachew Seid,Shewki Moga,Saro Abdella, Emebet Gashu,Kirubel Eshetu,Getachew Tollera,Mesay Hailu Dangisso,Balako Gumi

PloS one（2023）

引用 0|浏览6

暂无评分

摘要

Isoniazid mono-resistant TB patients had high poor treatment outcome. Thus, determination of isoniazid resistance pattern for all bacteriologically confirmed TB cases is critical for successful treatment outcome. PROSPERO registration number: CRD42022372367.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要